• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重新引入基因改造的自体骨髓基质细胞对犬进行人生长激素或人凝血因子IX的全身递送。

Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.

作者信息

Hurwitz D R, Kirchgesser M, Merrill W, Galanopoulos T, McGrath C A, Emami S, Hansen M, Cherington V, Appel J M, Bizinkauskas C B, Brackmann H H, Levine P H, Greenberger J S

机构信息

ALG Company, Marlboro, MA 01752, USA.

出版信息

Hum Gene Ther. 1997 Jan 20;8(2):137-56. doi: 10.1089/hum.1997.8.2-137.

DOI:10.1089/hum.1997.8.2-137
PMID:9017418
Abstract

Canine bone marrow stromal cells were expanded to numbers in excess of 10(9) cells from the initial 10-20 ml of marrow aspirates and transfected to express high levels of human growth hormone (hGH) in vitro. Ex vivo-modified marrow stromal cells were used in a gene therapy model system for the systemic delivery of transgene products in dogs. Adherent bone marrow stromal cell cultures, established and expanded from iliac crest marrow aspirates from each of 8 dogs, were transfected with a hGH gene plasmid expression vector and shown to express from 0.54-3.84 micrograms/10(6) cells per 24 hr hGH in vitro. The transfected plasmid vector does not possess a eukaryotic origin of replication nor does it possess sequences required for efficient integration into the host cell genome. As such, expression was expected to be transient. Transfected cells were autologously reintroduced into each dog by either infusion into a foreleg vein or directly into iliac crest marrow. In two cases, the stromal cells were cryopreserved following transfection, and subsequently thawed and infused. In one case, the expanded stromal cells were first cryopreserved, and then thawed, recultured, transfected, and infused. Reintroduced cell numbers ranged from 2.2 x 10(7) to 2.6 x 10(9), with total hGH expression capacities ranging from 62 to 1,400 micrograms/24 hr. Plasma of each of the dogs contained detectable hGH for a mean of 3.1 days (SD +/- 0.8 day) ranging from 2 to 5 days following reinfusion of cells. Peak plasma levels ranged from 0.10 to 1.76 ng/ml. Similar hGH expression values, based upon total expression capacity of the cells infused and dog body weight, were obtained for all dogs. Vector-modified stromal cells were detectable, by polymerase chain reaction (PCR) analysis, in the peripheral circulation following reinfusion in all 4 dogs analyzed. In 3 of the dogs, modified stromal cells were detected for 8.5-15 weeks. In addition, modified stromal cells were detected in iliac crest marrow of 2 dogs for 9 and 13 weeks, respectively, following reinfusion. In another experiment, cultured bone marrow stromal cells were transfected with a human factor IX (hFIX) plasmid vector. Modified cells (5.57 x 10(8)), with a total hFIX expression capacity of 281 micrograms/24 hr, were reinfused, resulting in detectable hFIX in plasma continuously for 9 days with a peak level of 8 ng/ml on day 1. These results demonstrate that the ex vivo bone marrow stromal cell system is a potentially powerful method by which to deliver secreted transgene product to the systemic circulation of large animals.

摘要

犬骨髓基质细胞从最初10 - 20毫升骨髓抽吸物中扩增至超过10⁹个细胞,并在体外转染以高水平表达人生长激素(hGH)。经体外修饰的骨髓基质细胞用于基因治疗模型系统,以在犬体内全身递送转基因产物。从8只犬的髂嵴骨髓抽吸物建立并扩增的贴壁骨髓基质细胞培养物,用hGH基因质粒表达载体转染,结果显示在体外每24小时每10⁶个细胞表达0.54 - 3.84微克hGH。转染的质粒载体不具有真核生物复制起点,也不具有有效整合到宿主细胞基因组所需的序列。因此,预期表达是短暂的。转染细胞通过注入前肢静脉或直接注入髂嵴骨髓自体重新引入每只犬体内。在2个案例中,基质细胞在转染后冷冻保存,随后解冻并注入。在1个案例中,扩增的基质细胞先冷冻保存,然后解冻、再培养、转染并注入。重新引入的细胞数量范围为2.2×10⁷至2.6×10⁹,hGH总表达能力范围为62至1400微克/24小时。每只犬的血浆在细胞回输后2至5天内平均3.1天(标准差±0.8天)可检测到hGH。血浆峰值水平范围为0.10至1.76纳克/毫升。基于注入细胞的总表达能力和犬体重,所有犬获得了相似的hGH表达值。通过聚合酶链反应(PCR)分析,在所有4只分析的犬回输后外周循环中可检测到载体修饰的基质细胞。在3只犬中,修饰的基质细胞在8.5 - 15周内被检测到。此外,回输后在2只犬的髂嵴骨髓中分别在9周和13周检测到修饰的基质细胞。在另一个实验中,培养的骨髓基质细胞用人类凝血因子IX(hFIX)质粒载体转染。将总hFIX表达能力为281微克/24小时的修饰细胞(5.57×10⁸)回输,导致血浆中hFIX连续9天可检测到,第1天峰值水平为8纳克/毫升。这些结果表明,体外骨髓基质细胞系统是一种潜在的强大方法,可将分泌的转基因产物递送至大型动物的全身循环。

相似文献

1
Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.通过重新引入基因改造的自体骨髓基质细胞对犬进行人生长激素或人凝血因子IX的全身递送。
Hum Gene Ther. 1997 Jan 20;8(2):137-56. doi: 10.1089/hum.1997.8.2-137.
2
Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion.逆转录病毒载体修饰的骨髓基质细胞在体外分泌具有生物活性的因子IX,并在重新输注后将治疗水平的人因子IX短暂递送至犬的血浆中。
Hum Gene Ther. 1998 Jul 1;9(10):1397-407. doi: 10.1089/hum.1998.9.10-1397.
3
In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro.转基因小鼠骨髓基质细胞在体内表达人生长激素及其对细胞的体外影响。
Cell Transplant. 2000 May-Jun;9(3):319-27. doi: 10.1177/096368970000900303.
4
Enhanced growth of canine bone marrow stromal cell cultures in the presence of acidic fibroblast growth factor and heparin.在酸性成纤维细胞生长因子和肝素存在的情况下犬骨髓基质细胞培养物的生长增强。
In Vitro Cell Dev Biol Anim. 1997 Jul-Aug;33(7):503-11. doi: 10.1007/s11626-997-0092-4.
5
Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.骨髓基质细胞作为体内治疗性蛋白质全身递送的遗传平台:人凝血因子IX模型
J Gene Med. 2003 Jan;5(1):11-7. doi: 10.1002/jgm.292.
6
Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.用人凝血因子IX表达质粒对骨髓间充质干细胞和造血细胞进行基因改造。
Biologicals. 2016 May;44(3):170-7. doi: 10.1016/j.biologicals.2016.01.002. Epub 2016 Feb 28.
7
Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.裸质粒体内转移后人类凝血因子IX的长期治疗水平肝脏基因表达
Mol Ther. 2001 Jun;3(6):947-57. doi: 10.1006/mthe.2001.0333.
8
Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy.腹腔内注射基因改造的人间皮细胞用于全身基因治疗。
Hum Gene Ther. 1997 Nov 1;8(16):1867-79. doi: 10.1089/hum.1997.8.16-1867.
9
Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX.
Hum Gene Ther. 1997 Jul 20;8(11):1385-94. doi: 10.1089/hum.1997.8.11-1385.
10
Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.骨髓基质细胞介导的血友病A基因治疗:具有高生物活性的人凝血因子VIII的体外表达需要包含氨基酸1648处的蛋白水解位点。
Hum Gene Ther. 1999 Jan 1;10(1):61-76. doi: 10.1089/10430349950019192.

引用本文的文献

1
Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence.干细胞操控、基因治疗与癌症干细胞出现的风险。
Stem Cell Investig. 2017 Jul 25;4:67. doi: 10.21037/sci.2017.07.03. eCollection 2017.
2
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?简明综述:纳米颗粒与细胞载体——癌症成像与细胞基因治疗的盟友?
Stem Cells. 2010 Sep;28(9):1686-702. doi: 10.1002/stem.473.
3
Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy.间充质干细胞:1型糖尿病治疗中的生物学特性及临床应用潜力
J Cell Mol Med. 2008 Aug;12(4):1155-68. doi: 10.1111/j.1582-4934.2008.00288.x. Epub 2008 Feb 24.
4
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.癌症中的间充质干细胞:肿瘤相关成纤维细胞和基于细胞的递送载体。
Int J Hematol. 2007 Jul;86(1):8-16. doi: 10.1532/IJH97.06230.
5
Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.间充质干细胞在遗传性和获得性疾病基因治疗方法中的潜力。
Expert Opin Biol Ther. 2005 Dec;5(12):1571-84. doi: 10.1517/14712598.5.12.1571.
6
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.使用经修饰的RD114包膜糖蛋白假型化的慢病毒载体转导骨髓间充质干细胞。
J Virol. 2004 Feb;78(3):1219-29. doi: 10.1128/jvi.78.3.1219-1229.2004.
7
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.骨髓细胞移植后成骨细胞特异性基因表达:对骨骼基因治疗的启示
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7294-9. doi: 10.1073/pnas.96.13.7294.